Symptom prevalence, characteristics and distress in a cancer population.
about
Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemo- or radiotherapy, or surgery)Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI)Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of CancerPain related to cancer treatments and diagnostic procedures: a no man's land?Integrating palliative care with intensive care for critically ill patients with lung cancer.Food insecurity among cancer patients in kentucky: a pilot study.Symptom clusters in women with breast cancer: an analysis of data from social media and a research study.Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease.Recent developments in palliative cancer care.Management of lung cancerIntervention to improve care at life's end in inpatient settings: the BEACON trial.Functional interference clusters in cancer patients with bone metastases: a secondary analysis of RTOG 9714.Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies.Cancer-Related Fatigue, Version 2.2015.Psychiatry and terminal illness.Trends in Cancer Pain Management.Assessing and treating pain in hospices: current state of evidence-based practicesDifferences in symptom clusters identified using occurrence rates versus symptom severity ratings in patients at the end of radiation therapy.Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapyExploring the differential experience of breast cancer treatment-related symptoms: a cluster analytic approach.Palliative care--an essential component of cancer controlHealth and personal resources in older patients with cancer undergoing chemotherapy.Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study.Suffering and dying in cancer patients. Research frontiers in controlling confusion, cachexia, and dyspneaPalliative care and rehabilitation.[Glucocorticoids and androgens for treatment of tiredness and weakness in palliative care patients : a systematic review].Pain experiences among a population-based cohort of current, former, and never regular smokers with lung and colorectal cancerPsychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study.Can a pain management and palliative care curriculum improve the opioid prescribing practices of medical residents?Symptom prevalence in lung and colorectal cancer patients.Cancer rehabilitation: experience, symptoms, and needs.Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders.Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer carePsychological Distress during Ovarian Cancer Treatment: Improving Quality by Examining Patient Problems and Advanced Practice Nursing InterventionsSomatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care useCancer related fatigue: A ubiquitous problem yet so under reported, under recognized and under treatedEarly referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacksThe Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients.A brief symptom index for advanced lung cancer.
P2860
Q24187427-6C45A148-48C6-4AAA-9E99-64775BAAF1DAQ24801760-B8281063-31F7-47C4-B05B-F44334BB678FQ26796389-586B4668-9935-40D9-9956-68B7772ECA38Q27026749-8D538C2B-3DF5-4732-B500-1C2D6032A843Q30427793-00247210-C56A-44E9-804C-BD5C4F743DC6Q30434763-C48645E4-AA98-4B1A-9E9C-AF41EF909CFDQ31007428-FDFA77BE-CA30-4B9B-B508-83AA7C755D69Q33466601-DA6862AB-5730-45CC-955E-4BA77F486EEFQ33537395-D27393EF-604B-4550-A093-02421BF929ABQ33583714-85F0C46D-7CB2-4E90-BFE3-3749902E2BF3Q33633158-BB793913-70DA-43BE-A1E3-D4017F75A116Q33756061-498F5847-01B9-4260-ADD8-97AD3B429FF7Q33762423-C619619C-E853-46F0-837A-9E767BF37056Q33878583-867AE600-102F-442D-8B6D-67FFEA79041CQ33878739-C0FAE412-5FCC-4FD8-A2BE-AF97CDC0DB33Q33887619-32A47ADA-402B-471C-ACBE-25551BF4561EQ33910318-78C513E5-A6C1-4597-8D5E-3064D1CEA33FQ33913624-E4F7EF8F-9156-4AE2-9FD0-B5B609E4E4F3Q33940740-84496A8E-A1E3-408D-97EF-75EE62541422Q33942013-B02997C1-301A-4119-8E90-441B2547C8DBQ34028975-AC9B1EDB-421A-4FD4-B6ED-73114886DF4EQ34073694-012E57D1-F838-404B-A247-E5017007CE8BQ34115856-3CCAD4CE-29EC-4377-AF10-F8EFA8D67FDFQ34181757-7564BE5D-8F3C-470C-99D4-E8F2A1C7A41EQ34344326-A1A49F4D-7F8D-441C-8E84-9BEB454BEA98Q34407540-F676C9A8-6140-4D77-BEEF-C21F3F4ADA97Q34458605-D3158159-FDCB-4E8F-9347-AD3FA6DFAC5BQ34599819-52C2AE99-0AA7-4E82-9979-C4761646753AQ34743293-9C946672-35D1-4E90-88B2-448C05F4E58FQ34777255-DBF60CB3-8B54-4F9C-BB7C-C7B705F4998AQ34853395-34687916-4299-4955-924C-3F1670DF40C4Q35059172-A8DC8C49-A946-42F4-91EE-14A90839FD94Q35084910-A02E8080-3FED-4D82-9AC0-45E3B0AE286EQ35155016-87DF657E-B2F1-435C-960B-C725DD733E28Q35205558-3D68CBEF-DC89-4F02-B30D-6BD49CD2EB0DQ35216630-224E7F5D-8D1C-4CAC-B528-8DB0D1D1AFCFQ35245489-EDD64095-CB55-4343-B3F0-604641E2BC58Q35354379-DE4394C4-4194-4DA7-979C-AD7DAFFDEDA3Q35685971-53499306-ECBB-4611-B7E3-721D3DF47845Q35801735-5B044699-FF2B-4308-BF8E-EE9764996FAF
P2860
Symptom prevalence, characteristics and distress in a cancer population.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Symptom prevalence, characteristics and distress in a cancer population.
@en
Symptom prevalence, characteristics and distress in a cancer population.
@nl
type
label
Symptom prevalence, characteristics and distress in a cancer population.
@en
Symptom prevalence, characteristics and distress in a cancer population.
@nl
prefLabel
Symptom prevalence, characteristics and distress in a cancer population.
@en
Symptom prevalence, characteristics and distress in a cancer population.
@nl
P2093
P356
P1476
Symptom prevalence, characteristics and distress in a cancer population.
@en
P2093
A B Kornblith
H Friedlander-Klar
H T Thaler
J M Lepore
R K Portenoy
T Smart-Curley
P2888
P304
P356
10.1007/BF00435383
P577
1994-06-01T00:00:00Z